Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists
2017 ◽
Vol 15
(2)
◽
pp. 229-239.e5
◽
2020 ◽
Keyword(s):
2012 ◽
Vol 16
(1)
◽
pp. 107-109
◽